Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
J Mol Neurosci ; 71(12): 2608-2617, 2021 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-34227035

RESUMEN

The process of ageing accompanies several metabolic diseases. With ageing, fats accumulate to increase the visceral and abdominal adiposity leading to hyperinsulinemia, insulin resistance, obesity and several other diseases. Drosophila melanogaster is often used to study the ageing process and its related disorders. Therefore, in this study, we performed an in silico analysis to relate the process of ageing and insulin resistance. We analysed the data of insulin-resistant Drosophila from the GEO database and compared it with the data from the literature survey. We observed that 98 genes were common in both the models, and they showed gene modulations related to metabolic pathways, fatty acid metabolism, insulin resistance and neural receptor-ligand binding pathways. Analysis of the REACTOME database against human data revealed that the TRKB signalling pathway is commonly affected. The TRKB-mediated BDNF pathway is a major regulator of memory loss. We further analysed the common genes in Alzheimer's disease and compared the fly data with human data to identify the diseases related to these common genes. Then, we performed a literature survey to provide protective mechanisms for the TRKB signalling pathway activation, mediated through polyphenols. We treated the flies with sesamol-conjugated lipoic acid derivative (a phenolic compound) at hormetic doses to evaluate its effect on the memory of flies.


Asunto(s)
Envejecimiento/genética , Enfermedad de Alzheimer/genética , Resistencia a la Insulina/genética , Obesidad/genética , Envejecimiento/metabolismo , Enfermedad de Alzheimer/metabolismo , Animales , Factor Neurotrófico Derivado del Encéfalo/genética , Factor Neurotrófico Derivado del Encéfalo/metabolismo , Proteínas de Drosophila/genética , Proteínas de Drosophila/metabolismo , Drosophila melanogaster , Genoma Humano , Genoma de los Insectos , Humanos , Obesidad/metabolismo , Receptor trkB/genética , Receptor trkB/metabolismo , Transducción de Señal
2.
Food Funct ; 11(2): 1198-1210, 2020 Feb 26.
Artículo en Inglés | MEDLINE | ID: mdl-32037412

RESUMEN

Phytophenols are important bioactive food based chemical entities, largely present in several natural sources. Among them, sesamol is one of the key natural phenols found in sesame seeds, Piper cubeba etc. Several studies have reported that sesame oil is a potent cardioprotective functional food. Papers on the utility of sesamol in sesame oil (the chemical name of sesamol is methylenedioxyphenol, MDP) have appeared in the literature, though there is no single concise review on the usefulness of sesamol in sesame oil in CVD in the literature. Cardiovascular disease (CVD) is the most challenging health problem encountered by the global population. There has been increasing interest in the growth of effective cardiovascular therapeutics, specifically of natural origin. Among various natural sources of chemicals, phytochemicals are micronutrients and bio-compatible scaffolds having an extraordinary efficacy at multiple disease targets with minimal or no adverse effect. This review offers a perspective on the existing literature on functional ingredients in sesame oil with particular focus on sesamol and its derivatives having nutritional and cardioprotective properties. This is demonstrated to have shown a specifically modulating oxidative enzyme myeloperoxidase (MPO) and other proteins which are detrimental to human well-being. The molecular mechanism of cardioprotection by this food ingredient is primarily attributed to the methylenedioxy group present in the sesamol component.


Asunto(s)
Benzodioxoles/uso terapéutico , Cardiotónicos/uso terapéutico , Fenoles/uso terapéutico , Aceite de Sésamo/uso terapéutico , Benzodioxoles/administración & dosificación , Cardiotónicos/administración & dosificación , Enfermedades Cardiovasculares/prevención & control , Humanos , Fenoles/administración & dosificación , Aceite de Sésamo/administración & dosificación
3.
Future Med Chem ; 12(2): 95-110, 2020 01.
Artículo en Inglés | MEDLINE | ID: mdl-31769316

RESUMEN

Aim: To evaluate new chemical entities, based on ferulic acid scaffolds, as reversible myeloperoxidase inhibitors (MPOI). Methodology & results:In silico docking studies are performed with MPO protein as a target for several ferulic acid analogs followed by multiple in vitro assays to validate this approach. Two lead compounds 2a and 3 are identified with optimum docking and IC50 values: -7.95 kcal/mol, 0.9 µM and -8.35 kcal/mol, 8.5 µM, respectively. These MPOIs are able to inhibit oxidation of high-density lipoprotein and further promoted functionality of high-density lipoprotein. Conclusion: Lead analogs are potent MPOIs that exert specific effects on MPO-mediated oxidation as well as inflammatory pathways. It also acts as promoters of cholesterol efflux that sheds light on pharmacological approach in atherosclerosis treatment.


Asunto(s)
Arteriosclerosis/tratamiento farmacológico , Ácidos Cumáricos/farmacología , Inhibidores Enzimáticos/farmacología , Peroxidasa/antagonistas & inhibidores , Fenoles/farmacología , Arteriosclerosis/metabolismo , Ácidos Cumáricos/síntesis química , Ácidos Cumáricos/química , Inhibidores Enzimáticos/síntesis química , Inhibidores Enzimáticos/química , Humanos , Simulación del Acoplamiento Molecular , Estructura Molecular , Oxidación-Reducción , Peroxidasa/metabolismo , Fenoles/síntesis química , Fenoles/química
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA